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The current therapies fail to deliver the drug to the alveolar macrophages in lungs, where 
causative agent resides, for the treatement of tuberculosis [1]. Hence, the ineffective drug 
delivery approaches lead to the drug toxicity and organ damage. Dry powder inahlers (DPIs) 
have recently shown promising results for the site specific drug delivery in the infectious 
diseases. Therefore, we developed nanoplexes based DPIs comprised of biocompatible 
polymer hyaluronic acid (HA) complexed with chitosan (CS), thiolated chitosan (TC) and 
mannsosylated chitosan (MC) individually to explore their affinity for alveolar macrophages to 
achieve higher drug deposition in deeper tissues of lungs. Nanoparticles were prepared by 
ionic gelation method [2] and later optimized by Design of Experiment (DoE), Box-Behnken 
design, prior to spray-drying to obtain nano-DPIs encapsulated with isoniazid. The size, 
morphology, physico-chemical properties, in-vitro release profile, in-vitro permeation, 
aerodynamic profile and in-silico drug deposition of the nano-powders were promising. 
Furthermore, biocompatibility assay revealed the safety profile of nanoplexes. Moreover, 
spray drying enhanced the rheological properties of nano-powders. Altogether, DPIs 
highlighted promising results based on the preliminary fundamental outcomes with enhanced 
drug encapsulation efficiency and drug deposition profile. 
 
Acknowledgements: This work was supported by the GINOP-2.3.2-15-2016-00036 
('Development and application of multimodal optical nanoscopy methods in life and materials 
sciences'), and Ministry of Human Capacities, Hungary grant TKP-2020. 
 
References  
1 Mukhtar, M. et al. Expert Opin. Drug Deliv, 17(9), 1239-1257 (2020). 
2 Mukhtar, M. et al. Int. J. Biol. Macromol. 165, 3007-3019 (2020) 
 
Supervisor: Rita Ambrus 
  
 
